| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.0063 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |